OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
Long Liu, Zaoqu Liu, Jie Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Long Liu, Zaoqu Liu, Jie Gao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
The emerging role of fatty acid binding protein 5 (FABP5) in cancers
W. G. Warren, Myles Osborn, Andrew Yates, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103628-103628
Open Access | Times Cited: 31
W. G. Warren, Myles Osborn, Andrew Yates, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103628-103628
Open Access | Times Cited: 31
Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma
Qizhi Fan, Yiyan Wang, Jun Cheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Qizhi Fan, Yiyan Wang, Jun Cheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Immune landscape of hepatocellular carcinoma tumor microenvironment identifies a prognostic relevant model
Hongru Cao, Ping Huang, Jiawei Qiu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24861-e24861
Open Access | Times Cited: 5
Hongru Cao, Ping Huang, Jiawei Qiu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24861-e24861
Open Access | Times Cited: 5
Role of lipid metabolism in hepatocellular carcinoma
Yulin Cheng, Jun He, Bin Zuo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Yulin Cheng, Jun He, Bin Zuo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Thikra Majid Muhammed, Saade Abdalkareem Jasim, Ahmed Hussein Zwamel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma
Anning Zuo, Jinyu Li, Siyuan Weng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 5, pp. 1821-1833
Closed Access | Times Cited: 3
Anning Zuo, Jinyu Li, Siyuan Weng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 5, pp. 1821-1833
Closed Access | Times Cited: 3
Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer
Siyuan Weng, Minghao Li, Jinhai Deng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Siyuan Weng, Minghao Li, Jinhai Deng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer
Zhaokai Zhou, Yuyuan Zhang, Jing Li, et al.
Cellular Signalling (2023) Vol. 109, pp. 110774-110774
Open Access | Times Cited: 8
Zhaokai Zhou, Yuyuan Zhang, Jing Li, et al.
Cellular Signalling (2023) Vol. 109, pp. 110774-110774
Open Access | Times Cited: 8
Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma
Haoran Zheng, Yimeng Li, Yujia Zhao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Haoran Zheng, Yimeng Li, Yujia Zhao, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Immune‐related interaction perturbation networks unravel biological peculiars and clinical significance of glioblastoma
Zaoqu Liu, Yudi Xu, Wang Yu-hui, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 7
Zaoqu Liu, Yudi Xu, Wang Yu-hui, et al.
iMeta (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 7
Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer
Huanfei Ding, Bowen Hu, Ruixia Guo
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298125-e0298125
Open Access | Times Cited: 2
Huanfei Ding, Bowen Hu, Ruixia Guo
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298125-e0298125
Open Access | Times Cited: 2
The sorafenib resistance-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
Tianxin Luo, Xiaomei Chen, Wei Pan, et al.
Cell Cycle (2024) Vol. 23, Iss. 2, pp. 150-168
Closed Access | Times Cited: 2
Tianxin Luo, Xiaomei Chen, Wei Pan, et al.
Cell Cycle (2024) Vol. 23, Iss. 2, pp. 150-168
Closed Access | Times Cited: 2
Themis: advancing precision oncology through comprehensive molecular subtyping and optimization
Yue Xi, Kun Zheng, Fulan Deng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 2
Yue Xi, Kun Zheng, Fulan Deng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 4
Open Access | Times Cited: 2
Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
Xiaokun Chen, Xiao Liu, Shunda Du
Cancers (2023) Vol. 15, Iss. 20, pp. 5046-5046
Open Access | Times Cited: 6
Xiaokun Chen, Xiao Liu, Shunda Du
Cancers (2023) Vol. 15, Iss. 20, pp. 5046-5046
Open Access | Times Cited: 6
scapGNN: A graph neural network–based framework for active pathway and gene module inference from single-cell multi-omics data
Xudong Han, Bing Wang, Chenghao Situ, et al.
PLoS Biology (2023) Vol. 21, Iss. 11, pp. e3002369-e3002369
Open Access | Times Cited: 6
Xudong Han, Bing Wang, Chenghao Situ, et al.
PLoS Biology (2023) Vol. 21, Iss. 11, pp. e3002369-e3002369
Open Access | Times Cited: 6
Predicting T Cell-Inflamed Gene Expression Profile in Hepatocellular Carcinoma Based on Dynamic Contrast-Enhanced Ultrasound Radiomics
Yijie Wang, Weixiang Weng, Ruiming Liang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2291-2303
Open Access | Times Cited: 6
Yijie Wang, Weixiang Weng, Ruiming Liang, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 2291-2303
Open Access | Times Cited: 6
Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment
Hui Xu, Xinyu Fu, Ben Liu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107871-107871
Open Access | Times Cited: 5
Hui Xu, Xinyu Fu, Ben Liu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107871-107871
Open Access | Times Cited: 5
Identification of PATL1 as a prognostic and immunotherapeutic predictive factor for nasal-type natural killer/T-cell lymphoma and head and neck squamous cell carcinoma
Wen Yang, Cong Peng, Zhengyang Li, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32158-e32158
Open Access | Times Cited: 1
Wen Yang, Cong Peng, Zhengyang Li, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32158-e32158
Open Access | Times Cited: 1
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
Yanbing Yang, Xuenian Ye, Haibin Zhang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
Yanbing Yang, Xuenian Ye, Haibin Zhang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
Long Liu, Jie Gao, Xudong Liu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21531-21544
Open Access | Times Cited: 3
The cellular trajectories of tumor-associated macrophages decipher the heterogeneity of pancreatic cancer
Jiajing Lin, Fengchun Lu, Yuwei Wu, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 1
Jiajing Lin, Fengchun Lu, Yuwei Wu, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 1
Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes
Yinglian Li, Yuan Fang, Dongli Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Yinglian Li, Yuan Fang, Dongli Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinoma
Wenda Zhang, Xinyi Zhou, Lili Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37327-e37327
Open Access
Wenda Zhang, Xinyi Zhou, Lili Lin, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37327-e37327
Open Access
The T cell-mediated tumor killing patterns revealed tumor heterogeneous and proposed treatment recommendation in ovary cancer
Xinglin Wen, Beining Yin, Li Lin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Xinglin Wen, Beining Yin, Li Lin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Perturbations in the ligand-receptor interactions unravel novel heterogeneous subtypes of stage II/III colorectal cancer
Xinwei Han, Hui Xu, Shuang Chen, et al.
Research Square (Research Square) (2023)
Open Access
Xinwei Han, Hui Xu, Shuang Chen, et al.
Research Square (Research Square) (2023)
Open Access
